Latest News
Feature
Women in medicine shout #MeToo about sexual harassment at work
Women are combating sexual harassment in the medical field at every level, from patients’ bedsides to the executive boardroom.
From the Journals
TACE plus radiotherapy improves outcomes in poor-prognosis hepatocellular carcinoma
Combined treatment with TACE plus external beam RT may represent a new treatment paradigm, providing improved patient survival compared with...
Daily News Podcast
MDedge Daily News: Stem cells may reverse premature menopause
And the Food and Drug Administration wants to snuff out nicotine in cigarettes.
News
FDA approves new option in Hodgkin lymphoma treatment
The approval is based on results from the ECHELON-1 trial in previously untreated patients with stage III or IV classical Hodgkin lymphoma.
News
FDA wants data on role of flavored tobacco products in youth initiation
“Youth consistently report product flavoring as a leading reason for using tobacco products,” FDA Commissioner Gottlieb noted.
Conference Coverage
Beware of polypharmacy in patients taking warfarin
SAN DIEGO – The incidence of polypharmacy among patients on warfarin therapy appears to peak at age 75.
Daily News Podcast
MDedge Daily News: MedPAC targets Medicare’s pay plans
And a gout drug has a puzzling link to cardiovascular deaths.
Conference Coverage
Fulvestrant plus neratinib reversed treatment-acquired HER2 mutations in metastatic ER+ breast cancer
The in vitro success has launched a phase 2 trial recruiting 152 patients.
Daily News Podcast
MDedge Daily News: Three daily meals best in type 2 diabetes
And new practice guidelines on testosterone therapy make their debut.
Conference Coverage
When it comes to thyroid cancer follow-up, serum microRNA profiles have earned new respect
CHICAGO – Serum thyroglobulin is not the only sheriff in town for thyroid cancer follow-up.
From the Journals
Axitinib/avelumab combo shows preliminary efficacy in RCC
Hypertension was the most common adverse event related to the treatment.